Sandbox 54321

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
==Your Heading Here (maybe something like 'Structure')== 0
+
<ref></ref>==Your Heading Here (maybe something like 'Structure')== 0
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
<StructureSection load='1stp' size='340' side='right' caption='Caption for this structure' scene=''>
This is a default text for your page '''Sandbox 54321'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
This is a default text for your page '''Sandbox 54321'''. Click above on '''edit this page''' to modify. Be careful with the &lt; and &gt; signs.
Line 5: Line 5:
== Function ==
== Function ==
-
Lisinopril is an orally active angiotensin-converting enzyme inhibitor, or ACE inhibitor, used primarily to lower blood pressure. Lisinopril works by antagonizing the effect of the RAAS, which is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from the granular cells of the juxtaglomerular apparatus in the kidneys. In the blood stream, renin cleaves circulating angiotensinogen to ATI, which is subsequently cleaved to ATII by ACE. ATII increases blood pressure using a number of mechanisms. ACE inhibitors inhibit the rapid conversion of ATI to ATII, and also antagonize RAAS-induced increases in blood pressure. ACE (also known as kininase II) is also involved in the enzymatic deactivation of bradykinin, which is a vasodilator. When the deactivation of bradykinin is inhibited, bradykinin levels are increased and this can further sustain the effects of lisinopril by causing increased vasodilation and decreased blood pressure. Overall, lisinopril inhibits the substances in the body that cause blood vessels to tighten, and as a result lisinopril relaxes the blood vessels and therefore lowers blood pressure and increases the supply of blood and oxygen to the heart.
+
Lisinopril is an orally active angiotensin-converting enzyme inhibitor, or ACE inhibitor, used primarily to lower blood pressure. Lisinopril works by antagonizing the effect of the RAAS, which is a homeostatic mechanism for regulating hemodynamics, water and electrolyte balance. During sympathetic stimulation or when renal blood pressure or blood flow is reduced, renin is released from the granular cells of the juxtaglomerular apparatus in the kidneys. In the blood stream, renin cleaves circulating angiotensinogen to ATI, which is subsequently cleaved to ATII by ACE. ATII increases blood pressure using a number of mechanisms. ACE inhibitors inhibit the rapid conversion of ATI to ATII, and also antagonize RAAS-induced increases in blood pressure. ACE (also known as kininase II) is also involved in the enzymatic deactivation of bradykinin, which is a vasodilator. When the deactivation of bradykinin is inhibited, bradykinin levels are increased and this can further sustain the effects of lisinopril by causing increased vasodilation and decreased blood pressure.<ref>National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119 </ref> Overall, lisinopril inhibits the substances in the body that cause blood vessels to tighten, and as a result lisinopril relaxes the blood vessels and therefore lowers blood pressure and increases the supply of blood and oxygen to the heart.<ref>Helen, Allen(2016). Lisinopril: Lisinopril ACE inhibitor. Patient. Retrieved from: http://patient.info/medicine/lisinopril-an-ace-inhibitor-zestril</ref>
== Structure ==
== Structure ==
-
<scene name='74/745973/Lisinopril_zinc/1'>Lisinopril</scene>is a synthetic angiotensin-converting enzyme inhibitor (ACE inhibitors) with molecular formula of C21+H31+N3+O5, empirical formula of C21+H31+N3+O5*2H2O, and average molecular weight of 405.495 g/mol. It is primarily used for the treatment of hypertension<ref>National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119 (accessed Nov. 12, 2016).</ref>. Lisinopril is typically in the trans isometric form because it has a lower steric repulsion between the hydroxyl and carboxyl groups than the cis conformation and is biologically active in this form<ref>Bouabdallah, S., Dhia, T. B., & Driss, R. (2014, February 25). Study of a Conformational Equilibrium of Lisinopril by HPLC, NMR, and DFT. Retrieved November 12, 2016, from https://www.hindawi.com/journals/ijac/2014/494719/</ref>.Lisinopril has a benzene ring and from there it has a 4-carbon amide chain where it branches of into a carboxylic acid group one way and a secondary amide group the other way which connects to the rest of the molecule. From the secondary amide, the molecule branches into a 5-carbon amine with a primary amide at the end. The other branch from the secondary amide has a ketone bonded to a nitrogen in a 4-carbon ring. From this carbon ring, there is a carboxylic acid group.
+
<scene name='74/745973/Lisinopril_zinc/1'>Lisinopril</scene>is a synthetic angiotensin-converting enzyme inhibitor (ACE inhibitors) with molecular formula of C21+H31+N3+O5, empirical formula of C21+H31+N3+O5*2H2O, and average molecular weight of 405.495 g/mol. It is primarily used for the treatment of hypertension. Lisinopril is typically in the trans isometric form because it has a lower steric repulsion between the hydroxyl and carboxyl groups than the cis conformation and is biologically active in this form (Bouabdallah).Lisinopril has a benzene ring and from there it has a 4-carbon amide chain where it branches of into a carboxylic acid group one way and a secondary amide group the other way which connects to the rest of the molecule. From the secondary amide, the molecule branches into a 5-carbon amine with a primary amide at the end. The other branch from the secondary amide has a ketone bonded to a nitrogen in a 4-carbon ring. From this carbon ring, there is a carboxylic acid group.
== Relevance ==
== Relevance ==
Line 25: Line 25:
== References ==
== References ==
<references/>
<references/>
- 
-
3. Helen, Allen(2016). Lisinopril: Lisinopril ACE inhibitor. Patient. Retrieved from: http://patient.info/medicine/lisinopril-an-ace-inhibitor-zestril
 
- 
- 
-
4. Natesh, R., Schwager, S.L.U., Sturrock, E.D., Acharya, K. R. (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex.Nature 421, 551-554 doi:10.1038/nature01370
 
- 
-
5. National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119 (accessed Nov. 12, 2016).
 
- 
-
6.
 

Revision as of 17:38, 12 November 2016

Cite error: Invalid <ref> tag; refs with no name must have content==Your Heading Here (maybe something like 'Structure')== 0

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. Hanson, R. M., Prilusky, J., Renjian, Z., Nakane, T. and Sussman, J. L. (2013), JSmol and the Next-Generation Web-Based Representation of 3D Molecular Structure as Applied to Proteopedia. Isr. J. Chem., 53:207-216. doi:http://dx.doi.org/10.1002/ijch.201300024
  2. Herraez A. Biomolecules in the computer: Jmol to the rescue. Biochem Mol Biol Educ. 2006 Jul;34(4):255-61. doi: 10.1002/bmb.2006.494034042644. PMID:21638687 doi:10.1002/bmb.2006.494034042644
  3. National Center for Biotechnology Information. PubChem Compound Database; CID=5362119, https://pubchem.ncbi.nlm.nih.gov/compound/5362119
  4. Helen, Allen(2016). Lisinopril: Lisinopril ACE inhibitor. Patient. Retrieved from: http://patient.info/medicine/lisinopril-an-ace-inhibitor-zestril
Personal tools